We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEPT
8426
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$75K ﹤0.01%
+12
New +$68.4K
SNR
8427
CALL
DELISTED
NEW SENIOR INVESTMENT GROUP INC.
SNR
$75K ﹤0.01%
11,200
-300
-3% -$1.84K
CARM
8428
DELISTED
Carisma Therapeutics
CARM
$74K ﹤0.01%
2,479
+1,677
+209% +$50.2K
XTKG
8429
DELISTED
X3 Holdings Co., Ltd. Class A Ordinary Shares
XTKG
0
NBRV
8430
CALL
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$74K ﹤0.01%
122
+53
+77% +$32.5K
JMEI
8431
CALL
DELISTED
Jumei International Holding Limited American depositary shares, each representing ten Class A ordina
JMEI
$74K ﹤0.01%
3,010
-30
-1% -$737
CNSL
8432
PUT
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$73K ﹤0.01%
14,800
-357,900
-96% -$2.28M
DS
8433
PUT
DELISTED
Drive Shack Inc.
DS
$73K ﹤0.01%
15,600
+5,300
+51% +$25.8K
TRQ
8434
PUT
DELISTED
Turquoise Hill Resources Ltd
TRQ
$73K ﹤0.01%
5,880
+730
+14% +$10.1K
HPJ
8435
CALL
DELISTED
Highpower International Inc
HPJ
$73K ﹤0.01%
17,100
+1,200
+8% +$3.97K
FCEL icon
8436
FuelCell Energy
FCEL
$1.79B
$72K ﹤0.01%
13,572
+13,334
+5,603% +$717K
NVLN
8437
DELISTED
Novelion Therapeutics Inc. Common Shares
NVLN
$72K ﹤0.01%
91,837
+31,150
+51% +$34.7K
ACRS icon
8438
Aclaris Therapeutics
ACRS
$851M
$71K ﹤0.01%
32,453
-156,388
-83% -$852K
GOGL
8439
CALL
DELISTED
Golden Ocean Group
GOGL
$71K ﹤0.01%
+12,200
New +$63.8K
HNRG icon
8440
PUT
Hallador Energy
HNRG
$762M
$71K ﹤0.01%
+12,600
New +$67.9K
XIN
8441
DELISTED
Xinyuan Real Estate
XIN
$71K ﹤0.01%
+1,687
New +$75.8K
NBRV
8442
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$71K ﹤0.01%
117
+44
+60% +$27K
CBL
8443
PUT
DELISTED
CBL& Associates Properties, Inc.
CBL
$71K ﹤0.01%
68,100
-41,600
-38% -$48.1K
SMRT
8444
DELISTED
Stein Mart Inc
SMRT
$71K ﹤0.01%
82,560
-2,348
-3% -$2.14K
ACHN
8445
CALL
DELISTED
Achillion Pharmaceuticals
ACHN
$71K ﹤0.01%
26,400
-11,100
-30% -$32.8K
APRN
8446
DELISTED
Blue Apron Holdings, Inc. Class A Common Stock
APRN
$70K ﹤0.01%
860
-511
-37% -$74.3K
GCVRZ
8447
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$70K ﹤0.01%
134,965
-87,250
-39% -$43.6K
GERN icon
8448
CALL
Geron
GERN
$943M
$69K ﹤0.01%
49,200
+8,300
+20% +$13.7K
IMNN icon
8449
Imunon
IMNN
$6.93M
$69K ﹤0.01%
193
-93
-33% -$37.9K
XNET
8450
CALL
Xunlei
XNET
$334M
$69K ﹤0.01%
26,500
-13,600
-34% -$41.9K

Similar funds

Ken Griffin's Q2 2019 Portfolio in Review

As of Q2 2019, Ken Griffin held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Ken Griffin deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Ken Griffin's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Ken Griffin added most to Netflix in Q2 2019, an estimated $400M increase.
  • Ken Griffin's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Ken Griffin fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Ken Griffin's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Ken Griffin opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Ken Griffin's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.